3505 results for «23»
3505 results
No flow!
22 May 2019 – From EuroPCR 2019
Consult this session to learn more about the management of no-reflow (particularly following PCI or coronary stenting), thanks to a selection of compelling cases.
The year in intervention: essential publications from the EuroIntervention Journal and the European Heart Journal
23 May 2019 – From EuroPCR 2019
Consult this session to discover the essential papers from the EuroIntervention Journal and the European Heart Journal in 2019, regarding hypertension, coronary interventions, and more!
Bioresorbable scaffold: new data, new hope?
22 May 2019 – From EuroPCR 2019
Consult this session on bioresorbable scaffold (BRS) to learn about new data and clinical outcomes: FAMTOM II trial, BIOSOLVE-IV registry, and more!
What every interventional cardiologist should know about new cardiovascular drugs
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about the impact of new cardiovascular drugs in patients with coronary artery disease, diabetes and other high-risk conditions, such as PCSK9 and SGLT-2 inhibitors, GLP1 agonists, and more!
Developing a successful CTO Programme
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about how to develop a successful CTO programme, while understanding the patient benefits of a CTO and maintaining radiation safety for staff and patient.
Planning mitral procedures: adding the third dimension
22 May 2019 – From EuroPCR 2019
Consult this session to learn all about 3D-planned mitral valve replacement procedures, and how it may help you to overcome challenging anatomies.
How to deal with thrombus during PCI for STEMI - Part 2
22 May 2019 – From EuroPCR 2019
Consult this session to learn innovative techniques and tools to efficiently deal with thrombus during PCI for STEMI, thanks to a selection of captivating cases: thrombus withdrawal in coronary bifurcation through a neurovascular thrombectomy device, stentless strategy using excimer laser and thrombus aspiration for STEMI with essential...
PCR e-Course 2020 Hot lines: TAVI – part 2
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on TAVI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: PORTICO IDE, FlexNav Delivery System, FRANCE TAVI, BIVOLUT-X, VIVALL.
Revascularisation strategies - PCR e-Course 2020 Hot lines
29 Jul 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on revascularisation presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: ISIS II, REDUCER-I, RINCAL, SYNTAX score II 2020.
CT guidance for coronary interventions - PCR e-Course 2020 Hot lines
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on CT-guidance for PCI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: CT-FFR CHINA, CAST-FFR, CT-QFR vs. myocardial perfusion imaging, CT-CTO trial, CCTA for optimal fluoroscopic coronary projections.
PCR e-Course 2020 Late-Breaking Trials - part 2
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice:
- 2-year safety of revascularisation deferral based on iFR or FFR
- CABG and PCI in patients with CTO and multivessel disease
- Routine revascularisation vs. medical therapy
PCR e-Course Hot Lines in STEMI interventions: First-in-Man and novel pharmacological strategies
27 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines in STEMI interventions presented during PCR e-Course 2020, followed by an analysis of these results and their impact on your practice: MOCA I Study, ON-TIME 3 trial, FABOLUS FASTER.
PCR e-Course Hot lines: drugs and devices for STEMI management
Watch this session to know more about ultrathin-strut vs thin-strut DES in patients with STEMI undergoing percutaneous coronary intervention (BIOSTEMI), RCT between bioresorbable and durable polymer stent by serial OCT assessment (MECHANISM-AMI), and the results of the FUNCOMBO trial.
Physiology or intracoronary imaging; or both? or none? - part 1
27 Jun 2020 – From PCR e-Course 2020
Watch a series of studies on physiology and intracoronary imaging presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: SCAAR report, a sub-analysis of the FORZA trial, diagnostic accuracy of IVUS-based FFR.
Left ventricular and systolic dimension determines anatomic suitability for transcatheter mitral valve implantation
25 Jun 2020 – From PCR e-Course 2020
A common exclusion for transcatheter mitral valve implantation (TMVI) is a small predicted neo-left ventricular outflow tract (LVOT). Simulation of the neoLVOT is time-consuming, requires multi-detector computerised tomography (MDCT), specialised software, and computer models of the prosthesis. Measurements that do not require neoLVOT simulation may provide...
PCR e-Course 2020 Hot line: left atrial appendage closure
27 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on LAA closure presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: LAA occlusion vs. NOAC, Amulet IDE Roll-in cohort, identification of potential LAAC candidates.
New TMVI therapy to eliminate mitral regurgitation. Evidence and patient selection
26 Jun 2020 – From PCR e-Course 2020
Watch this video if you want to get the latest update on the first commercially available TMVI therapy (Tendyne), to learn about Tendyne clinical experience and how to identify the best candidates for this novel therapy.
Physiology or intracoronary imaging; or both? or none? - part 2
27 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on physiology and intracoronary imaging presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: SOCT-PCI Study, impact of PPG index on PCI, angiography-derived IMR.
Two-year outcomes of Tendyne Transcatheter Mitral Valve Implementation (TMVI) to treat symptomatic severe mitral regurgitation
Learn more about the 2-year outcomes of the first 100 patients treated as part of the Tendyne Expanded Clinical Study, and how the latest Tendyne clinical evidence may change the way the heart team treats mitral regurgitation.
Videos included on this page: the Hot Line presentation and...
Shaping care pathways for severe aortic stenosis patients in a COVID-19 context
Watch this roundtable discussion on the management of aortic stenosis in the context of the COVID-19 pandemic and how to readdress the treatment options and pathways to serve the needs of the patients in this difficult global crisis.
